Proteostasis Therapeutics' IPO

Proteostasis Therapeutics raised a round of funding on February 11, 2016. Investors include Public.

Proteostasis Therapeutics is developing disease-modifying therapeutics for diseases of protein processing. By combining the DRT platform, a phenotypic screening approach based on the use of functional…

Articles about Proteostasis Therapeutics' IPO: